Location History:
- Sayama, JP (1982 - 1992)
- Warabi, JP (1995 - 1998)
- Warabi-shi, Saitama-ken, JP (1998)
- Saitama, JP (1994 - 2003)
Company Filing History:
19 out of 128 
18 out of 776 
1 out of 832,843 Years Active: 1982-2003
Title: The Innovative Contributions of Koichi Niimura
Introduction
Koichi Niimura is a prominent inventor based in Saitama, Japan. With an impressive portfolio of 38 patents, he has made significant contributions to the field of pharmaceuticals. His innovative work, particularly in developing chondroprotective agents, showcases his expertise and dedication to advancing medical science.
Latest Patents
Among his latest inventions is a pharmaceutical composition described as an aromatase-inhibiting composition containing an azole derivative. This disclosure includes a compound effective in inhibiting aromatase activity. The composition consists of a compound selected from various formulas and configurations, including stereoisomers and salts. Specifically, the formula is characterized by different substituents (R groups) that provide specificity and efficacy in pharmacological applications.
Career Highlights
Throughout his career, Koichi Niimura has worked with renowned companies such as Kureha Chemical Industry Company, Limited and Kureha Kagaku Kogyo Kabushiki Kaisha. His role in these organizations has been instrumental in fostering innovation and delivering breakthrough solutions in the pharmaceutical sector.
Collaborations
Niimura's journey has been marked by collaborations with notable professionals like Takao Ando and Chikao Yoshikumi. These partnerships have not only enriched his research but have also amplified the impact of their collective efforts within the realm of medicinal chemistry.
Conclusion
Koichi Niimura stands as a testament to the potential of innovation in the pharmaceutical industry. His patents not only reflect his inventiveness but also contribute to better healthcare solutions. Through continuous research and collaboration, he remains a key figure in the advancement of therapeutic agents, potentially impacting countless lives.